In 1992, a researcher named Dr. Paul Talalay at the Johns Hopkins School of Medicine published a paper in the Proceedings of the National Academy of Sciences that quietly changed how researchers think about cellular repair.
His team had isolated a single plant compound, sulforaphane, from common broccoli — and demonstrated that it activated a master regulator inside human cells called NRF2.
NRF2 was, in plain language, the body's repair switch. When NRF2 turns on, over 200 protective genes turn on at the same time. Tight junction proteins — claudins, occludin, ZO-1 — get reinforced. Inflammatory cytokines like IL-6 and IL-1 beta get suppressed. Glutathione, the body's primary internal antioxidant, surges.
The story made the front page of The New York Times. Popular Mechanics listed Talalay's discovery as one of the great scientific findings of the 20th century. He founded an entire field of medicine called chemoprotection.
Two years later, his mentee Dr. Jed Fahey reported something more remarkable still. The three-day-old broccoli sprout — the seedling that comes up before the mature head of broccoli forms — contained 20 to 50 times more sulforaphane than the broccoli most people actually eat.
For the next two decades, the research on sulforaphane built quietly. Most of it focused on inflammation and cell repair in general. Then around 2015, the gut research started arriving.
Sulforaphane reinforced tight junction proteins in human gut tissue (PubMed 30302904).
Sulforaphane reversed LPS-induced changes in gut permeability (Tandfonline 2021).
Sulforaphane reduced colonic inflammation in human ulcerative colitis patients (PMC10487861).
Sulforaphane modulated the gut microbiome from the lining inward — actually increasing populations of Faecalibacterium and Bifidobacterium, the two bacterial groups most depleted in IBS patients (Frontiers in Physiology, 2025).
And in 2023, a peer-reviewed review concluded with a sentence that should have made bigger news than it did:
"Appropriately dosed sulforaphane has been clinically demonstrated to eliminate IBS symptoms."
PMC10487861, 2023.
The compound that activates the gut's repair switch is the same compound that, when delivered in the right form, has been shown to address the upstream cause of IBS at the lining level.
That is the part of the story most gastroenterologists have not gotten around to reading.